Consumption of β-casomorphins-7/5 induce inflammatory immune response in mice gut through Th2 pathway

Journal of Functional Foods

Volumn 8, Issue 1, 2014, Pages 150-160

  Haq, Mohammad Raies Ul ^a   Kapila, Rajeev ^a   Saliganti, Vamshi ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

BCM 5; BCM 7; Cytokines; Humoral immune response; Inflammation; Casomorphins

Indexed keywords

EID: 84899937773     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.03.018     Document Type: Article

References (60)

1. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology 1982, 78(3):206-209.
2. Brantl V., Teschemacher H., Blasig J., Henschen A., Lottspeich F. Opioid activities of β-casomorphins. Life Sciences 1981, 28(17):1903-1909.
3. Brantl V., Teschemacher H., Henschen A., Lottspeich F. Novel opioid peptides derived from casein (β-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seyler's Zeitschrift fur Physiologische Chemie 1979, 360(9):1211-1216.
4. Chang K.J., Su Y.F., Brent D.A., Chang J.K. Isolation of a specific mu-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins. Journal of Biology and Chemistry 1985, 260(17):9706-9712.
5. Clare D.A., Swaisgood H.E. Bioactive milk peptides: A prospectus. Journal of Dairy Science 2000, 83(6):1187-1195.
6. Conti P., DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy and Asthma Proceedings 2001, 22(3):133-137.
7. Corfield A.P., Carroll D., Myerscough N., Probert C.S. Mucins in the gastrointestinal tract in health and disease. Frontiers in Bioscience 2001, 6:1321-1357.
8. De Noni I. Release of β-casomorphins -5 and -7 during simulated gastro-intestinal digestion of bovine β-casein variants and milk-based infant formulas. Food Chemistry 2008, 110:897-903.
9. De Noni I., Cattaneo S. Occurrence of β-casomorphins-5 and -7 in commercial dairy products and in their digests following in vitro simulated gastro-intestinal digestion. Food Chemistry 2010, 119(2):560-566.
10. Dharmani P., Srivastava V., Kissoon-Singh V., Chadee K. Role of intestinal mucins in innate host defense mechanisms against pathogens. Journal of Innate Immunity 2009, 1(2):123-135.
11. Dupont C., Heyman M. Food protein-induced enterocolitis syndrome: Laboratory perspectives. Journal of Pediatric Gastroenterology and Nutrition 2000, 30S:50-57.
12. Elitsur Y., Luk D.A. B-Casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation. Clinical Experimental Immunology 1991, 85(3):493-497.
13. Elliot R.T., Martin J.M. Dietary protein: A trigger of insulin dependent diabetes in BB rat?. Diabetologia 1984, 26(4):297-299.
14. Elliott R.B., Wasmuth H., Hill J. Immunosuppressing effects of cow milk β-casomorphins in prediabetic mice and humans 1997, 16th IDF Congress, Helsinki.
15. Faridah M.N., Shahrom A.W. Comparative histamine levels in antemortem and postmortem wounds in the human skin by fluorescence spectrophotometry. Malaysian Journal of Pathology 2011, 23(2):111-114.
16. Farrell H.M., Jimenez-Flores R., Bleck G.T., Brown E.M., Butler J.E., Creamer L.K., Hicks C.L., Hollar C.M., Ng-Kwai-Hang K.F., Swaisgood H.E. Nomenclature of the proteins of cow's milk. Journal of Dairy Science 2004, 87(6):1641-1674.
17. Fiedorowicz E., Jarmołowska B., Iwan M., Kostyra E., Obuchowicz R., Obuchowicz M. The influence of μ-opioid receptor agonist and antagonist peptides on peripheral blood mononuclear cells (PBMCs). Peptides 2011, 32(4):707-712.
18. Gutiérrez-Venegas G., Cruz-Arrieta S., Villeda-Navarro M., Méndez-Mejía J.A. Histamine promotes the expression of receptors TLR-2 and TLR-4 and amplifies sensitivity to lipopolysaccharide and lipoteichoic acid treatment in human gingival fibroblasts. Cell Biology International 2011, 35(10):1009-1017.
19. Han D.N., Zhang D.H., Wang L.P., Zhang Y.S. Protective effect of β-casomorphin-7 on cardiomyopathy of streptozotocin-induced diabetic rats via inhibition of hyperglycemia and oxidative stress. Peptides 2013, 44:120-126.
20. Hausmann M., Kiessling S., Mestermann S., Webb G., Spöttl T., Andus T., Schölmerich J., Herfarth H., Ray K., Falk W., Rogler G. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002, 122(7):1987-2000.
21. Hayre M.O., Salanga C.L., Handel T.M., Allens S.J. Chemokines and cancer: Migration, intracellular signaling, and intercellular communication in the microenvironment. Biochemical Journal 2008, 409(3):635-649.
22. Hutchinson M.R., Zhang Y., Shridhar M., Evans J.H., Buchanan M.M., Zhao T.X., Slivka P.F., Coats B.D., Rezvani N., Wieseler J., Hughes T.S., Landgraf K.E., Chan S., Fong S., Phipps S., Falke J.J., Leinwand L.A., Maier S.F., Yin H., Rice K.C., Watkins L.R. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain, Behavior, and Immunity 2010, 24(1):83-95.
23. Jarmołowskaa B., Teodorowiczb M., Fiedorowicza E., Sienkiewicz-Szłapkaa E., Matysiewicza M., Kostyraa E. Glucose and calcium ions may modulate the efficiency of bovine β-casomorphin-7 permeability through a monolayer of Caco-2 cells. Peptides 2013, 49:59-67.
24. Jinsmaa Y., Yoshikawa M. Enzymatic release of neocasomorphin and β-casomorphin from bovine β-casein. Peptides 1999, 20(8):957-962.
25. Kashiwadaa M., Levyb D.M., McKeaga L., Murraya K., Schröderb A.J., Canfield S.M., Traver G., Rothman P.B. IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(2):821-826.
26. Kiernan J.A. Histological and Histochemical Methods: Theory and Practice 2008, Scion, UK, Bloxham. 4th.
27. Korhonen H. Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods 2009, 1(2):177-187.
28. Korhonen H., Pihlanto A. Bioactive peptides: Production and functionality. International Dairy Journal 2006, 16(9):945-960.
29. Kurek M., Czerwionka-Szaflarska M., Doroszewska G. Pseudoallergic skin reactions to opiate sequences of bovine casein in healthy children. Roczniki Akademii Medycznej W Bialymstoku 1995, 40(3):480-485.
30. Kurek M., Przybilla B., Hermann K., Ring J. A naturally occurring opioid peptide from cow's milk, β-casomorphin-7, is a direct histamine releaser in man. International Archives of Allergy and Applied Immunology 1992, 97(2):115-120.
31. Laugesen M., Elliott R. Ischaemic heart disease, type 1 diabetes, and cow milk A1 β-casein. Journal of the New Zealand Medical Association 2003, 116(1168):U295.
32. Martien A.M., Groenen J., Van der Poel J. Regulation of expression of milk protein genes: A review. Livestock Production Science 1994, 38:61-78.
33. McLachlan C.N.S. B-casein A1, ischaemic heart disease mortality, and other illnesses. Medical Hypotheses 2001, 56(2):262-272.
34. Meisel H., Frister H. Chemical characterization of bioactive peptides from in vivo digests of casein. Journal of Dairy Research 1989, 56(3):343-349.
35. Previatia M., Raspadorib A., Bertolasoa L., Parmeggiania A., Bindini D., Vitali C., Lanzoni I., Corbacella E., Saviano M., Fagioli F., Blo G., Capitani S. Determination of histamine in the whole blood of colon cancer patients. Journal of Chromatography B 2002, 780:331-339.
36. Proost P., Wuyts A., Damme V.J. Human monocyte chemotactic proteins-2 and -3: Structural and functional comparison with MCP-1. Journal of Leucocyte Biology 1996, 59:67-74.
37. Raies M.H., Kapila R., Shandilya U.K., Dang A.K., Kapila S. Detection of A1 and A2 genetic variants of β-casein in Indian crossbred cattle by PCR-ACRS. Milchwissenschaft 2012, 67(4):396-398.
38. Raies M.H., Kapila R., Shandilya U.K., Kapila S. Impact of milk derived β-casomorphins on physiological functions and trends in research: A review. International Journal of Food Properties 2014, 10.1080/10942912.2012.712077.
39. 2 mediated inflammatory response in mouse gut. European Journal of Nutrition 2013, 10.1007/s00394-013-0606-7.
40. Reddi S., Kapila R., Dang A.K., Kapila S. Evaluation of allergenic response of milk bioactive peptides using mouse mast cell. Milchwessienschaft 2011, 67:117-121.
41. Rollins B.J., Pobert J.S. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. American Journal of Pathology 1991, 138(6):1315-1319.
42. Rollins B.J., Sunday M.E. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Molecular Cell Biology 1991, 11(6):3125-3131.
43. Rungkat-Zakaria R.F., Belleville F., Nabet F., Linden G. Allergenicity of bovine casein. I: Specific lymphocyte proliferation and histamine accumulation in the mastocytes as a result of casein feeding in mice. Food and Agricultural Immunology 1992, 4:41-50.
44. Schlimme E., Meisel H. Bioactive peptides derived from milk-proteins-structural, physiological and analytical aspects. Die Nahrung 1995, 39(1):1-20.
45. Schneider E., Rolli-Derkinderen M., Arock M., Dy M. Trends in histamine research: New functions during immune responses and hematopoiesis. Trends in Immunology 2002, 23(5):255-263.
46. Svedberg J., de Haas J., Leimenstoll G., Paul F., Teschemacher H. Demonstration of β-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides 1985, 6(5):825-830.
47. Tailford K.A., Berry C.L., Thomas A., Campbell J.H. Casein variant in cow's milk is atherogenic. Atherosclerosis 2003, 170(1):13-19.
48. Talreja J., Kabir M.H., Filla B.M., Stechschulte D.J., Dileepan K.N. Histamine induces toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to gram-positive and gram-negative bacterial cell wall components. Immunology 2004, 113(2):224-233.
49. Teschemacher H. Opioid receptor ligands derived from food proteins. Current Pharmaceutical Design 2003, 9(16):1331-1344.
50. Thornhill M.H., Kyan-Aung U., Haskard D.O. IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. Journal of Immunology 1990, 144(8):3060-3065.
51. Trompette A., Claustre J., Caillon F., Jourdan G., Chayvialle J.A., Plaisancie P. Milk bioactive peptides and β-casomorphins induce mucus release in rat jejunum. Journal of Nutrition 2003, 133(11):3499-3503.
52. Waugh D.J.J., Wilson C. The interleukin-8 pathway in cancer. Clinical Cancer Research 2008, 14(21):6735-6741.
53. Woodford K. The devil in the Milk A1 or A2? How β-caseins are changing the dairy industry. American Council on Rural Special Education 2009, 39(12).
54. Woodford K. Milk protein and human health: A1 versus A2 β-casein 2011, An address to the general practitioners conference, Sydney.
55. Yadav A., Saini V., Arora S. MCP-1: Chemoattractant with a role beyond immunity: A review. Clinical Chimica Acta 2010, 411(21-22):1570-1579.
56. Yin H., Miao J., Zhang Y. Protective effect of β-casomorphin-7 on type 1 diabetes rats induced with streptozotocin. Peptides 2010, 31(9):1725-1729.
57. Zhang L., Li L., Zhang G. A Crassostrea gigas toll-like receptor and comparative analysis of TLR pathway in invertebrates. Fish and Shellfish Immunology 2011, 30(2):656-660.
58. Zhang W., Miao J., Ma C., Han D., Zhang Y. β-casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells. Peptides 2012, 36(2):186-191.
59. Zhang W., Miao J., Wang S., Zhang Y. The protective effects of β-casomorphin-7 against glucose-induced renal oxidative stress in vivo and vitro. PLoS ONE 2013, 8:e63472.
60. Zoghbi S., Trompette A., Claustre J., El Homsi M., Garzón J., Jourdan G., Scoazec J.Y., Plaisancié P. β-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a μ-opioid pathway. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006, 290(6):G1105-G1113.